Internal Medicine Alert – May 30, 2005
May 30, 2005
View Issues
-
What You Can't See Will Hurt You (and Your Patient)
Concealed renal insufficiency is common and contributes to adverse drug reactions from hydrosoluble medications. -
Asymptomatic Mitral Regurgitation: When is it Appropriate to Repair or Replace?
Patients with an effective regurgitant orifice of at least 40 mm2 should promptly be considered for cardiac surgery. -
Special Report: Bad News About the COX-2 Inhibitors
There has been enormous controversy regarding the benefit/safety relationship of the COX-2 inhibitors, which were initially introduced in 1999. This is a cautionary tale. -
Pharmacology Update: Micafungin Infusion (MycamineTM)
The FDA has approved a new intravenous antifungal agent. -
Clinical Briefs
Management of asthma in America remains problematic, with as many as 5,000 deaths annually in recent years.